文献速递胃肠外科

腹腔镜完整结肠系膜切除联合中央血管结扎治疗脾曲结肠癌的短期与长期结局

Laparoscopic complete mesocolic excision with central vascular ligation for splenic flexure colon cancer: short- and long-term outcomes.
PubMed 文献 · Surg Endosc · 2021-05-24

中位手术时间178分钟,中位估计出血量20克,围术期并发症发生率为13.3%,中位术后住院9天,中位清扫淋巴结15枚,淋巴结转移14例(31.1%)。中位随访49个月,5年累积总生存率和无病生存率分别为85.9%和84.7%,I-III期癌症特异性生存率为92.7%,复发5例(11.1%)。结论认为该手术在肿瘤学上安全可行,但需谨慎开展并积累更多病例以确定适应证。

要点

  • 腹腔镜CME联合CVL治疗脾曲结肠癌在短期和长期结局中显示肿瘤学安全可行。
  • 中位清扫淋巴结15枚,淋巴结转移率31.1%,未发现结肠中动脉或肠系膜下动脉根部转移。
  • 5年总生存率85.9%,无病生存率84.7%,I-III期癌症特异性生存率92.7%。

核心结论

  • 基于本研究的短期和长期结局,腹腔镜CME联合CVL治疗脾曲结肠癌在肿瘤学上似乎是安全可行的。
  • 但引入该手术需谨慎,要求术者具备解剖理解能力和手术技巧,且需更多病例登记以确定合适适应证。

主要发现

  • 所有患者均成功完成腹腔镜CME联合CVL。
  • 中位手术时间178分钟,中位估计出血量20克。
  • 围术期并发症6例(13.3%),中位术后住院9天。
  • 中位清扫淋巴结15枚,淋巴结转移14例(31.1%),结肠中动脉或肠系膜下动脉根部未见转移。
  • 中位随访49个月,5年累积总生存率85.9%,无病生存率84.7%,I-III期癌症特异性生存率92.7%,复发5例(11.1%),包括腹膜播散3例和远处转移2例。

临床怎么用

  • 对于脾曲结肠癌,腹腔镜CME联合CVL可由具备解剖理解能力和手术技巧的术者谨慎开展。
  • 需注意围术期并发症风险(13.3%)和中位术后住院9天。
  • 长期随访显示5年总生存率85.9%、无病生存率84.7%,可作为预后参考。

局限性

  • 需更多病例登记以建立合适的适应证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complete mesocolic excision (CME) with central vascular ligation (CVL) for colon cancer is an essential procedure for improved oncologic outcomes after surgery. Laparoscopic surgery for splenic flexure colon cancer was recently adopted due to a greater understanding of surgical anatomy and improvements in surgical techniques and innovative surgical devices. METHODS: We retrospectively analyzed the data of patients with splenic flexure colon cancer who underwent laparoscopic CME with CVL at our institution between January 2005 and December 2017. RESULTS: Forty-five patients (4.8%) were enrolled in this study. Laparoscopic CME with CVL was successfully performed in all patients. The median operative time was 178 min, and the median estimated blood loss was 20 g. Perioperative complications developed in 6 patients (13.3%). The median postoperative hospital stay was 9 days. According to the pathological report, the median number of harvested lymph nodes was 15, and lymph node metastasis developed in 14 patients (31.1%). No metastasis was observed at the root of the middle colic artery or the inferior mesenteric artery. The median follow-up period was 49 months. The cumulative 5-year overall survival and disease-free survival rates were 85.9% and 84.7%, respectively. The cancer-specific survival rate in stage I-III patients was 92.7%. Recurrence was observed in 5 patients (11.1%), including three patients with peritoneal dissemination and two patients with distant metastasis. CONCLUSIONS: Laparoscopic CME with CVL for splenic flexure colon cancer appears to be oncologically safe and feasible based on the short- and long-term outcomes in our study. However, it is careful to introduce this procedure to necessitate the anatomical understandings and surgeon's skill. The appropriate indications must be established with more case registries because our experience is limited.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ueda K, Daito K, Ushijima H, et al. Laparoscopic complete mesocolic excision with central vascular ligation for splenic flexure colon cancer: short- and long-term outcomes. Surg Endosc. 2021. PMID: 34031741. doi:10.1007/s00464-021-08559-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。